Clinico-epidemiological profile and treatment outcome of craniopharyngioma: a case series
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20232471Keywords:
Craniopharyngioma, Surgery, RadiationAbstract
Craniopharyngioma is a rare type of benign (non-cancerous) brain tumor that primarily affects children and young adults. It arises from remnants of the Rathke's pouch, which is an embryonic structure that forms during the development of the pituitary gland. Craniopharyngiomas typically develop near the pituitary gland, in the area known as the sellar region. These tumors can cause various symptoms depending on their size and location, including hormonal imbalances, vision problems, headaches, and growth abnormalities. The management of craniopharyngioma involves a multidisciplinary approach, including surgery, radiation therapy, and hormone replacement therapy. Long-term outcomes can be influenced by the tumor's size, location, and the treatment modality used. Therefore, early recognition, accurate diagnosis, and appropriate treatment are crucial for optimizing the quality of life and long-term prognosis for individuals with craniopharyngioma. A detailed review of a number of craniopharyngioma cases is presented in this case series publication, with an emphasis on the clinical presentation, diagnostic methods, therapeutic options, and long-term results. This study's goal is to give doctors and researchers who work with patients who have this difficult malignancy useful information.
Metrics
References
Müller HL, Merchant TE, Puget S, MartinezBarbera JP. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol. 2017;13(5):299-312.
Müller HL. Childhood craniopharyngioma— current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol. 2010;6(11):609-18.
Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas. Endocr Rev. 2006;27(4):371-97.
Müller HL. Paediatrics: surgical strategy and quality of life in craniopharyngioma. Nat Rev Endocrinol. 2013;9(8):447-9.
Hoffmann A, Boekhoff S, Gebhardt U, Sterkenburg AS, Daubenbüchel AM, Eveslage M, et al. History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis. Eur J Endocrinol. 2015;173(6):853-62.
Müller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab. 2004;89(7):3298-305.
Boekhoff S, Bison B, Eveslage M, Sowithayasakul P, Muller HL. Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007. Pituitary. 2019;22(5):532-41.
Caldarelli M, Massimi L, Tamburrini G, Cappa M, Di Rocco C. Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome. Childs Nerv Syst. 2005;21(8-9):747-57.
Müller HL. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res. 2008;69(4):193-202.
Kassam AB, Gardner PA, Snyderman CH, Carrau RL, Mintz AH, Prevedello DM. Expanded endonasal approach, a fully endoscopic transnasal approach for the resection of midline suprasellar craniopharyngiomas: a new classification based on the infundibulum. J Neurosurg. 2008;108(4):715-28.
Mou J, Wang X, Huo G, Ruan L, Jin K, Tan S, Wang F, Hua H, Yang G. Endoscopic Endonasal Surgery for Craniopharyngiomas: A Series of 60 Patients. World Neurosurg. 2019;124:e424-30.
Fujio S, Juratli TA, Arita K, Hirano H, Nagano Y, Takajo T, et al. A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas. Neurosurgery. 2019;85(2):204-10.
Thompson CJ, Costello RW, Crowley RK. Management of hypothalamic disease in patients with craniopharyngioma. Clin Endocrinol (Oxf). 2019;90(4):506-16.
O'steen L, Indelicato DJ. Advances in the management of craniopharyngioma. F1000Res. 2018;7.
Maira G, Anile C, Albanese A, Cabezas D, Pardi F, Vignati A. The role of transsphenoidal surgery in the treatment of craniopharyngiomas. J Neurosurg. 2004;100:445-51.
Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg. 1999;90:237-50.
Barkhoudarian G, Laws ER. Craniopharyngioma: history. Pituitary. 2013;16:1-8.
Varlotto J, DiMaio C, Grassberger C, Tangel M, Mackley H, Pavelic M, et al. Multi-modality management of craniopharyngioma: a review of various treatments and their outcomes. Neurooncol Pract. 2016;3(3):173-87.
Elwatidy SM, Jamjoom ZA, Jamjoom AB, Yakoub AO. Craniopharyngioma. Analysis of factors that affect the outcome. Saudi Med J. 2002;23:34-8.
Merchant TE, Kun LE, Hua CH, Wu S, Xiong X, Sanford RA, et al. Disease control after reduced volume conformal and intensity modulated radiation therapy for childhood craniopharyngioma. Int J Radiat Oncol Biol Phys. 2013;85(4):187-92.
Merchant TE, Kiehna EN, Kun LE, Mulhern RK, Li C, Xiong X, et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg. 2006;104(2):92-104.
Hader WJ, Steinbok P, Hukin J, Fryer C. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg. 2000;33(4):211–218.
Jiang R, Liu Z, Zhu C. Preliminary exploration of the critical effect of bleomycin on cranipharyngiomas. Stereotact Funct Neurosurg. 2002;78(2):84-94.
Takahashi H, Yamaguchi F, Teramoto A. Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children. Childs Nerv Syst. 2005;21(8–9):701-4.
Dastoli PA, Nicacio JM, Silva NS. Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon. Arq Neuropsiquiatr. 2011;69(1):50-5.
